Skip to main content
. 2015 May 14;21(18):5473–5481. doi: 10.3748/wjg.v21.i18.5473

Figure 5.

Figure 5

Dihydromyricetin protects from CCl4-induced acute liver failure by up-regulating JNK activation both in liver injury mice and acute liver failure mice. A: Western blots depicting JNK pathway proteins on day 2 after CCl4 (1 mL/kg) injection; B: Western blots depicting JNK pathway proteins on day 2 after CCl4 (2.6 mL/kg) injection with or without of SP600125 treatment; C: The survival curves of the different conditions (n = 30/group).